Study Testing Behavioral Messages to Encourage Repeat HIV Testing Among Adults at Risk in Kenya and Uganda
Led by University of California, San Francisco · Updated on 2026-01-26
40000
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate several low-cost behavioral strategies designed with user input to encourage adults at higher risk of HIV exposure in rural Kenya and Uganda to retest for HIV. Enrolling 30,000 to 40,000 participants aged 15 and older, the study focuses on improving early disease detection and preventing further transmission by promoting repeat HIV testing.
Participants will be randomly assigned to one of up to 12 groups receiving different interventions, such as video messages and SMS reminders based on various motivational themes like risk assessment, community benefits, social norms, and goal-setting. One group will receive a small financial incentive to encourage retesting, while another will receive standard care messaging. The interventions are delivered at baseline and followed up with reminders around 8 and 11 weeks later.
Throughout the study, participants will be monitored for HIV retesting uptake measured 3 to 6 months after enrollment. Researchers will collect data to assess which strategies most effectively increase retesting rates and also track secondary outcomes like PrEP uptake. Participation includes initial visits, message delivery, and follow-up assessments, with the total involvement spanning at least 3 to 6 months.
CONDITIONS
Brief Title
IBIS Megastudy of Interventions to Encourage HIV Retesting
Research Team
K
Kara Marson, MPH
G
Gabriel Chamie, MD, MPH
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Accessing HIV testing services at study-associated hospitals or clinics
At increased risk of HIV infection based on national criteria in Kenya or Uganda
Documented negative HIV antibody test at time of enrollment
No plans to move out of the community in the next 3 months
Daily access to a mobile phone
You will not qualify if you...
Known HIV-positive status at time of enrollment
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Outpatient Treatment
Duration - 3 to 6 months
Participants view a brief video message at their baseline visit with information encouraging repeat HIV testing, followed by SMS reminders at about 8 and 11 weeks after baseline to reinforce the message and encourage retesting.
1 baseline visit and periodic SMS messages at about 8 and 11 weeks
Follow-up
Duration - Within 3 to 6 months after baseline visit
Participants return for repeat HIV testing to assess uptake of retesting and any related outcomes.
1 follow-up visit (in-person)
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SCREENING
Number of Arms
12
Similar Trials
Improving HIV Testing in European Hospitals by Introducing Dedicated HIV Teams A Multicenter Study Across Ten Countries
Pilot Study to Prevent Frailty in People Living with HIV Aged 65 to 74
Remote Tai ChiQigong vs Health Education for Depression in Older Adults Living with HIV A Randomized Clinical Trial
Reducing Chlamydia Disparities in Black Youth Through Community-Based Testing and Treatment in the Deep South
Evaluating Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adults Without HIV Using Multiple Doses and Routes
Randomized Trial to Improve Muscle Health and Reduce Fat in Veterans with HIV and Obesity
Phase 1 Study of GRAdHIVNE1 Vaccine for Adults With and Without HIV in Southern Africa
Evaluation of DV700P-RNA and DV701B1.1-RNA Vaccines with Antiretroviral Treatment Interruption in Adults Living with HIV
Improving Cervical Cancer Screening and Treatment for Women Living with HIV in Nigeria Using Enhanced Implementation Strategies
Studying Immune and Viral Changes During Early HIV Infection
Using Combination Anti-Retroviral Therapy
A Long-Term Observational Study
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
A megastudy of behavioral interventions to promote frequent HIV testing among adults at high risk of HIV infection in Kenya and Uganda: study protocol for a randomized controlled trial.